Targeted treatments engineered for high-efficiency poultry and livestock health management, delivering exceptional clinical results across modern agricultural enterprises.
Chișinău, serving as the political, economic, and cultural epicenter of Moldova, anchors a vital agricultural and livestock supply chain in Eastern Europe. The region's expanding poultry, swine, and ruminant sectors demand rigorous biosecurity protocols and advanced veterinary therapeutics. As intensive farming models scale up across Chișinău and surrounding districts, managing respiratory challenges—such as Mycoplasmosis, Infectious Bronchitis, and Pasteurellosis—has become paramount for maintaining farm productivity and economic viability.
Local veterinary practitioners and large-scale agricultural enterprises in Chișinău require dependable import channels for pharmaceutical-grade raw materials and formulated therapeutics. By partnering with world-class manufacturers who understand European quality standards, local distributors can secure consistent inventory, precise dosage forms, and optimized formulations that withstand regional climatic variations and seasonal stressors.
The global veterinary respiratory care medicine market is projected to experience robust CAGR expansion, driven by rising meat consumption, stringent animal welfare regulations, and an increased focus on preventative herd health management. Supply chain resilience and rapid access to active pharmaceutical ingredients (APIs) are now core competitive differentiators for international B2B buyers.
China stands as the undisputed global powerhouse for API synthesis and advanced pharmaceutical formulation. Leveraging vertically integrated supply chains, state-of-the-art fermentation facilities, and rigorous automated quality control, Chinese manufacturing bases offer unmatched cost-efficiency without compromising on international pharmacopeia compliance (USP, BP, EP).
Xian QLU Health Pharmaceutical Technology Co., Ltd. is a premier enterprise engaged in the comprehensive development, production, and international marketing of pharmaceutical products, active pharmaceutical ingredients (APIs), food ingredients, vitamins, intermediates, and high-purity chemicals.
Headquartered in Xi'an, China, QLU operates three dedicated production bases strategically located in Shandong, Zhejiang, and Hebei provinces. These advanced manufacturing hubs possess decades of cumulative expertise in API synthesis and vitamin production, holding prestigious international certifications including GMP, ISO, FAMI-QS, KOSHER, and HALAL.
With robust strategic marketing partners established in global hubs like Mumbai and Dubai, QLU maintains absolute control over product design, development, and inspection, ensuring optimal therapeutic efficacy for clients in Chișinău and across the globe.
Partner With Us
Explore our extensive inventory designed for distributors, veterinary clinics, and animal husbandry operations seeking premium respiratory and systemic care medicines.
We partner with accredited international logistics providers experienced in cold-chain and pharmaceutical freight. All shipments are securely packaged adhering to international export standards, accompanied by full customs clearance documentation and certificate of analysis (COA).
Yes. Our production bases in Shandong, Zhejiang, and Hebei hold rigorous international certifications including GMP, ISO, FAMI-QS, KOSHER, and HALAL, ensuring complete compliance with global regulatory benchmarks.
Absolutely. We specialize in OEM and ODM services, offering private labeling (such as custom packaging for Doxycycline and soluble powders) tailored to regional branding and regulatory requirements in Chișinău.
Standard production and dispatch lead times range between 15 to 25 days depending on the formulation volume and specific regulatory documentation required for export.
QLU Health
